The FDA cleared TransMed’s SpeedBird platform used for soft tissue biopsies.

The device is made up of a single element constructed from three hypodermic tubes with twin opposed cutter blades. It can be fully automated or manually operated and provides a pathway to transport multiple tissue samples by using a closed-circuit flush and vacuum mechanism that sends the samples into a removable chamber.

It is intended to address issues with current biopsy devices, such as sharp and potentially traumatic needle tips and needle gauge and tissue type restrictions.